EGFR and neoplasm: Alternately, as a substrate protein of EGFR, ANXA1 may contribute to neoplasm growth via autocrine and paracrine effects and sustain the preinvasive properties of malignant cancers through autocrine signaling induced by the N-terminal peptide [21].